...
首页> 外文期刊>General and comparative endocrinology >Oestrogen and insulin-like growth factors during the reproduction and growth of the tilapia Oreochromis niloticus and their interactions
【24h】

Oestrogen and insulin-like growth factors during the reproduction and growth of the tilapia Oreochromis niloticus and their interactions

机译:罗非鱼尼罗罗非鱼繁殖和生长期间的雌激素和胰岛素样生长因子及其相互作用

获取原文
获取原文并翻译 | 示例

摘要

Oestrogens and insulin-like growth factors (Igfs) play both a central role in the regulation of reproduction and growth and can interact especially in species showing a clear-cut sex-linked growth dimorphism (SGD) like in tilapia. Aromatase is essential in ovarian differentiation and oogenesis since it controls oestrogen synthesis. During tilapia sex differentiation, aromatase cypl9ala expression increases from 9 days post-fertilization (dpf), resulting in high oestradiol level. High temperature, exogenous androgens or aromatase inhibitors override genetic sex differentiation inducing testes development through the suppression of cyp19a1a gene expression and aromatase activity. Supplementation with 17 beta-oestradiol (E2) of gonadectomized juveniles induced a sustained and higher E2 plasma level than in intact or gonadectomized controls and both sexes showed reduced growth. juvenile and mature females treated with the aromatase inhibitor 1,4,6-androstatriene-3,17-dione had 19% lower E2 plasma level compared to controls and they showed a 32% increased growth after 28 days of treatment. Altogether, these data suggest that E2 inhibits female growth leading to the SGD. Regarding Igf-1, mRNA and peptide appeared in liver at 4 dpf and then in organs involved in growth and metabolism, indicating a role in early growth, metabolism and organogenesis. Gonad igf-1 showed an early expression and the peptide could be detected at 7 dpf in somatic cells. It appeared in germ cells at the onset of ovarian (29 dpf) and testicular (52 dpf) meiosis. In testis, Igf-1 together with steroids may regulate spermatogenesis whereas in ovary it participates in steroidogenesis regulation. Igf-1 and Igf-2 promote proliferation of follicular cells and oocyte maturation. Igf-3 expression is gonad specific and localized in the ovarian granulosa or testicular interstitial cells. In developing gonads igf-3 is up-regulated in males but down-regulated in females. In contrast, bream Gh injections increased igf-1 mRNA in male and female liver and ovaries but gonadal igf-3 was not affected. Thus, local Igf-1 and Igf-2 may play crucial roles in the formation, development and function of gonads while Igf-3 depending on the species is involved in male and female reproduction. Furthermore, precocious ethynylestradiol (EE) exposure induced lasting effects on growth, through pituitary gh inhibition, local suppression of igf-1 expression and in testis only down-regulation of igf-3 mRNA. In conclusion, SGD in tilapia may be driven through an inhibitory effect due to E2 synthesis in female and involving Igfs regulation. (C) 2014 Elsevier Inc. All rights reserved.
机译:雌激素和胰岛素样生长因子(Igfs)在生殖和生长的调节中起着核心作用,并且可以相互作用,尤其是在像罗非鱼中显示出明显的性别相关的生长二态性(SGD)的物种中。芳香酶在卵巢分化和卵子形成中至关重要,因为它控制着雌激素的合成。在罗非鱼性别分化期间,从受精后的9天(dpf)开始,芳香化酶cypl9ala表达增加,从而导致高雌二醇水平。高温,外源性雄激素或芳香酶抑制剂通过抑制cyp19a1a基因表达和芳香化酶活性,超越了遗传性别分化诱导的睾丸发育。补充17个β-雌二醇(E2)的性腺切除的少年比完整或性腺切除的对照组诱导的E2血浆水平持续升高,并且两性均显示生长降低。与对照组相比,用芳香酶抑制剂1,4,6-androstatriene-3,17-dione治疗的雌性和成年雌性的E2血浆水平降低了19%,治疗28天后,其生长增长了32%。总而言之,这些数据表明E2抑制了导致SGD的女性生长。关于Igf-1,mRNA和肽在4 dpf时出现在肝脏中,然后在参与生长和代谢的器官中出现,这表明它在早期生长,代谢和器官发生中起作用。 Gonad igf-1显示早期表达,并且可以在体细胞中以7 dpf的浓度检测到该肽。它在卵巢减数分裂(29 dpf)和睾丸减数分裂(52 dpf)发作时出现在生殖细胞中。在睾丸中,Igf-1与类固醇一起可能调节精子发生,而在卵巢中,它参与类固醇发生的调节。 Igf-1和Igf-2促进卵泡细胞增殖和卵母细胞成熟。 Igf-3表达是性腺特异性的,位于卵巢颗粒或睾丸间质细胞中。在发育中的性腺中,igf-3在雄性中上调,而在雌性中下调。相比之下,Gh注射增加了男性和女性肝脏和卵巢中igf-1的mRNA,但性腺igf-3并未受到影响。因此,局部Igf-1和Igf-2可能在性腺的形成,发育和功能中起关键作用,而取决于物种的Igf-3参与雄性和雌性繁殖。此外,早熟的乙炔雌二醇(EE)暴露通过垂体gh抑制,igf-1表达的局部抑制以及在睾丸中仅对igf-3 mRNA的下调而诱导对生长的持久影响。总之,罗非鱼中的SGD可能是由于雌性E2合成并涉及Igfs调节而产生的抑制作用所驱动。 (C)2014 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号